Amit Rajan

Amit Rajan

Active Director Director DIN 03264797
DIN 03264797 First appointment Nov 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 3 historical roles
Total affiliations 6 Since Nov 2010
Shareholding value •••• Premium profile

About Amit Rajan

Data last updated:

Amit Rajan is a Director at Prosfora Technologies Private Limited (since 2015), Director at Gpax Pharmaceuticals Private Limited (since 2015) and Director at Celogen Lifescience & Technologies Private Limited (since 2010). The companies operate in Pharma and Travel and Hospitality. The 3 current companies with reported revenue have a combined latest revenue of ₹144 Cr; the largest is Prosfora Technologies Private Limited at ₹125 Cr (FY 2025). Earlier, Amit Rajan was a Director at Kopran Limited (2012–2016) and Director at Bioture Labs Private Limited (2015–2021) and 1 more.

DIN 03264797
Primary Designation Director
Industry Pharma
First Appointment 11 Nov 2010
Oldest Company Age 16 yrs
Largest company Prosfora Technologies Private Limited · ₹125 Cr (FY 2025)
Combined revenue ₹144 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Mar 20152015₹125 Cr (FY 2025)Active
Gpax Pharmaceuticals Private Limited U24233MH2014PTC258452
Director02 Jan 20152014₹18.67 Cr (FY 2025)Active
Director11 Nov 20102010₹28.6 Lakh (FY 2023)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kopran Limited L24230MH1958PLC011078
Director13 Jul 20121958₹629 Cr (FY 2024)Active
Bioture Labs Private Limited U85190GJ2013PTC076792
Director19 Feb 20152013₹2.54 Cr (FY 2025)Active
Celogen Laboratories Private Limited U51109MH2012PTC226572
Director02 Feb 20122012₹22,000 (FY 2021)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Gpax Pharmaceuticals Private Limited
Celogen Lifescience & Technologies Private Limited
Prosfora Technologies Private Limited
Kopran Limited
Premium access

Shareholding and investment profile for Amit Rajan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amit Rajan

Amit Rajan currently holds 3 directorships: Prosfora Technologies Private Limited (Director, since 30 Mar 2015, revenue ₹125 Cr (FY 2025)); Gpax Pharmaceuticals Private Limited (Director, since 02 Jan 2015, revenue ₹18.67 Cr (FY 2025)); Celogen Lifescience & Technologies Private Limited (Director, since 11 Nov 2010, revenue ₹28.6 Lakh (FY 2023)).

Amit Rajan was first appointed on 11 Nov 2010 as Director at Celogen Lifescience & Technologies Private Limited. The most recent appointment on record is 30 Mar 2015 at Prosfora Technologies Private Limited.

The 3 current companies of Amit Rajan that report revenue have a combined latest revenue of ₹144 Cr: Prosfora Technologies Private Limited ₹125 Cr (FY 2025); Gpax Pharmaceuticals Private Limited ₹18.67 Cr (FY 2025); Celogen Lifescience & Technologies Private Limited ₹28.6 Lakh (FY 2023).

Amit Rajan held 3 earlier board appointments: Kopran Limited (Director, 13 Jul 2012 to 28 Apr 2016); Bioture Labs Private Limited (Director, 19 Feb 2015 to 15 Jan 2021); Celogen Laboratories Private Limited (Director, 02 Feb 2012 to 29 May 2015).

The current boards of Amit Rajan's companies include Ruchi Amit Rajan (Prosfora Technologies Private Limited), Anuj Somchand Bhagwanji Shah (Gpax Pharmaceuticals Private Limited), Bharat Kakubhai Katariya (Gpax Pharmaceuticals Private Limited), Rabi Narayan Nayak (Gpax Pharmaceuticals Private Limited), Shailesh Kakulal Kataria (Gpax Pharmaceuticals Private Limited), Thykoottathil Rajan Matthews (Gpax Pharmaceuticals Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available